Japanese drugmaker Eisai and its U.S. partner Biogen had announced earlier this fall that the drug lecanemab appeared to work, a badly needed bright spot after repeated disappointments in the quest for better Alzheimer's treatments.
Now the companies are providing full results of the study of nearly 1,800 people in the earliest stages of the mind-robbing disease. The data was presented at an Alzheimer's meeting in San Francisco and published in The New England Journal of Medicine. U.S. regulators could approve the drug as soon as January.
Every two weeks for 18 months, study participants received intravenous lecanemab or a dummy infusion. Researchers tracked them using an 18-point scale that measures cognitive and functional ability.
Those given lecanemab declined more slowly a difference of not quite half a point on that scale, concluded the research team led by Dr. Christopher van Dyck at Yale University.
That's a hard-to-understand change, but measured a different way, lecanemab delayed patients' worsening by about five months over the course of the study, Eisai's Dr. Michael Irizarry told. Also, lecanemab recipients were 31% less likely to advance to the next stage of the disease during the study.
"That translates to more time in earlier stages" when people function better, Irizarry said.
But doctors are divided over how much difference those changes may make for patients and families.
この記事は AppleMagazine の AppleMagazine #579 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、8,500 以上の雑誌や新聞にアクセスしてください。
すでに購読者です ? サインイン
この記事は AppleMagazine の AppleMagazine #579 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、8,500 以上の雑誌や新聞にアクセスしてください。
すでに購読者です? サインイン
US ADVANCES REVIEW OF NEVADA LITHIUM MINE AMID CONCERNS OVER ENDANGERED WILDFLOWER
The Biden administration has taken a significant step in its expedited environmental review of what could become the third lithium mine in the U.S., amid anticipated legal challenges from conservationists over the threat they say it poses to an endangered Nevada wildflower.
TENSIONS BETWEEN BEIJING AND WASHINGTON ARE THE BIGGEST WORRY FOR US COMPANIES IN CHINA.REPORT SAYS
Simmering tensions between Beijing and Washington remain the top worry for American companies operating in China, according to a report by the American Chamber of Commerce in China released this week.
MICROSOFT & AMAZON FACE SCRUTINY FROM UK COMPETITION WATCHDOG OVER RECENT AI DEALS
British competition regulators said this week they’ll scrutinize recent artificial intelligence deals by Microsoft and Amazon over concerns that the moves could thwart competition in the AI industry.
OLYMPIC ORGANIZERS UNVEIL STRATEGY FOR USING ARTIFICIAL INTELLIGENCE IN SPORTS
Olympic organizers unveiled their strategy to use artificial intelligence in sports, joining the global rush to capitalize on the rapidly advancing technology.
THE SUMMER AFTER BARBENHEIMER AND THE STRIKES, HOLLYWOOD CHARTS A NEW COURSE
“Barbenheimer” is a hard act to follow. But as Hollywood enters another summer movie season, armed with fewer superheroes and a landscape vastly altered by the strikes, it’s worth remembering the classic William Goldman quote about what works: “Nobody knows anything.”
NETFLIX NOW HAS NEARLY 270 MILLION SUBSCRIBERS AFTER ANOTHER STRONG SHOWING TO BEGIN 2024
Netflix gained another 9.3 million subscribers to start the year while its profit soared with the help of a still-emerging expansion into advertising, but caught investors off guard with a change that will make it more difficult to track the video streaming service’s future growth.
BOEING POSTS A $355 MILLION LOSS AS THE PLANE MAKER TRIES TO DIG OUT FROM UNDER ITS LATEST CRISIS
Boeing said this week that it lost $355 million on falling revenue in the first quarter, another sign of the crisis gripping the aircraft manufacturer as it faces increasing scrutiny over the safety of its planes and accusations of shoddy work from a growing number of whistleblowers.
WHAT YOU NEED TO KNOW ABOUT WRAPPING YOUR CAR
Gaze around the next time you’re stuck in traffic and see if you’re not surprised, maybe even a little saddened, by the monochromatic sea around you.
APPLE PULLS WHATSAPP AND THREADS FROM APP STORE ON BEIJING'S ORDERS
Apple said it had removed Meta’s WhatsApp messaging app and its Threads social media app from the App Store in China to comply with orders from Chinese authorities.
WALL STREET IS LOOKING TO TESLA'S EARNINGS FOR CLUES TO MUSK'S PLAN TO RESTORE COMPANY'S WILD GROWTH
But Wall Street was unimpressed and will be looking for other answers from CEO Elon Musk when Tesla releases a report on its first-quarter finances after the U.S. stock market’s closing bell Tuesday.